Created by AMTZ LTD, Biovalley Incubation Council brings together manufacturing, academics, QA labs, investors connections and two dedicated business incubation hubs – Biovalley for the nutra space and Medivalley for medical equipment.
It seeks to help firms achieve full commercialisation of their products, by removing obstacles around manufacturing, research and investment.
Two recently signed deals will lead to Biovalley working with Pulse Pharma and Zenova Life Sciences.
The former is keen to commercialise medical devices and clinical nutrition products developed at Biovalley, while Zenova Life Sciences is striving to do the same with new nutraceuticals and functional foods.
Amit Srivastava, from Biovalley, said there were currently five firms with links to the hub, with more expected to be confirmed in the coming weeks.
He said the hub could help with access to new technology and innovation, foster collaboration, assist with regulatory requirements, fast-track product development and aid marketing efforts.
“The hybridisation of technology is the major focus,” he said.
“For instance, stents can be used as sustained and specialised nutraceutical delivery device; AI can be used for targeted nutrition selection for cancer therapy; and the Internet of Medical Things (IoMT) can help with screening and predicting iron content and haemoglobin.”